nasal bpc-157 + TB-500 Spray intranasal bpc-157 study Injection vs

7864 (29.3%) were not admitted to SU

Results: Thirty-four patients were included (n = 36, as two of them underwent a second contralateral carotid revascularisation)

Antioxidant activities: According to France research, engineered Lactococcus lactis as a delivery vehicle for BPC-157 demonstrates antioxidant activity, reducing ROS production in cell models (5)

BPC-157 is particularly notable for its ability to promote angiogenesis, enhance collagen production, and accelerate tissue repair in tendons, ligaments, muscles, bones, and gastrointestinal tissue

Essentially a Copy: Compounded drugs cannot mimic patented, commercially available medications

The Human Iron-Proteome